N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation

Cited by (228)

Items 101–200 of 228

1. Biomarkers Associated with Stroke Risk in Atrial Fibrillation
   Adam Ioannou, Νικόλαος Παπαγεωργίου, Debbie Falconer, Onkar Rehal, Emma Sewart, Effimia Maria Zacharia, Konstantinos P. Toutouzas, Charalambos V. Vlachopoulos, Gerasimos Siasos, Costas P. Tsioufis et al. · 2017 · Current Medicinal Chemistry
2. Difficulties in diagnosis of heart failure with preserved ejection fraction in clinical practice: dissonance between echocardiography, NTproBNP and H2HFPEF score
   Yu. V. Mareev, Гарганеева Алла Анатольевна, Olga V. Tukish, Т. Yu. Rebrova, D. V. Anikina, V. Yu. Mareev · 2020 · Kardiologiia
3. Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.
   Ioanna C. Koniari, Eleni Artopoulou, Dimitrios Velissaris, Mark Ainslie, Virginia Mplani, Georgia Karavasili, Nicholas George Kounis, Grigorios Tsigkas · 2021 · PubMed Central
4. Relation of Obesity to Outcomes of Hospitalizations for Atrial Fibrillation
   Manyoo A. Agarwal, Lohit Garg, Mahek Kishor Shah, Brijesh D. Patel, Neha Jain, Sameer Jain, Rajesh Kabra, Csaba Pal Kovesdy, Guy L. Reed, Carl J. Lavie · 2019 · The American Journal of Cardiology
5. A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
   Luxiang Shang, Ling Zhang, Yankai Guo, Huaxin Sun, Xiaoxue Zhang, Yakun Bo, Xianhui Zhou, Baopeng Tang · 2021 · Frontiers in Cardiovascular Medicine
6. Stroke in Atrial Fibrillation and Other Atrial Dysrhythmias
   Hizir Ozdemir, Dimitrios Sagris, Gregory Y.H. Lip, Azmil H. Abdul‐Rahim · 2023 · Current Cardiology Reports
7. Plasma angiopoietin-2 and its association with heart failure in patients with atrial fibrillation
   Alexander Philipp Benz, Ziad Hijazi, Johan Lindbäck, Stuart J. Connolly, John W. Eikelboom, Peter Kastner, André Ziegler, John Hunter Alexander, Christopher Bull Granger, Renato D. Lópes et al. · 2023 · EP Europace
8. Prognostic Importance of B-Type Natriuretic Peptide Level in Patients Undergoing Catheter Ablation for Atrial Fibrillation
   Tetsuma Kawaji, Satoshi Shizuta, Takanori Aizawa, Shushi Nishiwaki, Takashi Yoshizawa, Suguru Nishiuchi, Masashi Kato, Takafumi Yokomatsu, Shinji Miki, for the TRANQUILIZE AF Registry Investigators · 2023 · Circulation Journal
9. Symptom burden, Metabolic profile, Ultrasound findings, Rhythm, neurohormonal activation, haemodynamics and health-related quality of life in patients with atrial Fibrillation (SMURF): a protocol for an observational study with a randomised interventional component
   Emmanouil Charitakis, Ulla Walfridsson, Fredrik Hans Nyström, Eva Nylander, Anna Strömberg, Urban Alehagen, Håkan Walfridsson · 2015 · BMJ Open
10. Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA 2 DS 2 -VASc Score 1 in Men, 2 in Women) Be Anticoagulated?
    John A. Savino, Jonathan L. Halperin · 2016 · Circulation
11. Biomarkers of Atrial Fibrillation: Which One Is a True Marker?
    Pipin Ardhianto, Yoga Yuniadi · 2019 · Cardiology Research and Practice
12. Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas
    Tymon Pol, Ziad Hijazi, Johan Lindbäck, John Hunter Alexander, Maria Cecilia Bahit, Raffaele De Caterina, John W. Eikelboom, Michael D. Ezekowitz, Bernard John Gersh, Christopher Bull Granger et al. · 2021 · Open Heart
13. Secondary Stroke Prevention Following Embolic Stroke of Unknown Source in the Absence of Documented Atrial Fibrillation: A Clinical Review
    Irum Kotadia, Iain Sim, Rahul K Mukherjee, Daniel O’Hare, Amedeo Chiribiri, Jonathan Birns, Ajay Bhalla, Mark D O'Neill, Steven Edwin Williams · 2021 · Journal of the American Heart Association
14. Apixaban to prevent stroke in patients with atrial fibrillation: a review
    Benjamin E. Peterson, Sana M. Al‐Khatib, Christopher Bull Granger · 2016 · Therapeutic Advances in Cardiovascular Disease
15. Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation
    Gian Marco De Marchis, Philipp Krisai, Laura Werlen, Tim Sinnecker, Stefanie Aeschbacher, Tolga Daniel Dittrich, Alexandros A. Polymeris, Michael Coslovsky, Manuel R. Blum, Nicolas Rodondi et al. · 2023 · Stroke
16. Ischemic Stroke in Acute Decompensated Heart Failure: From the KCHF Registry
    Moritake Iguchi, Takao Kato, Hidenori Yaku, Takeshi Morimoto, Yasutaka Inuzuka, Yodo Tamaki, Neiko Ozasa, Erika Yamamoto, Yusuke Yoshikawa, Takeshi Kitai et al. · 2021 · Journal of the American Heart Association
17. Individual net clinical outcome with oral anticoagulation in atrial fibrillation using the ABC‐AF risk scores
    Ziad Hijazi, Johan Lindbäck, Jonas Oldgren, Alexander Philipp Benz, John Hunter Alexander, Stuart J. Connolly, John W. Eikelboom, Christopher Bull Granger, Renato D. Lópes, Agneta G Siegbahn et al. · 2023 · American Heart Journal
18. Atrial Fibrillation: Biomarkers Determining Prognosis
    Savas Mazaris, Gerasimos Siasos, Evangelos K. Oikonomou, Vicky Tsigkou, Manolis Vavuranakis, Eleni Kokkou, Marina Zaromitidou, George-Angelo Papamikroulis, Athanasios G. Papavassiliou, Spyridon Papaioannou et al. · 2017 · Current Medicinal Chemistry
19. N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy
    Gerald Chi, James L. Januzzi, Serge Korjian, Yazan Daaboul, Samuel Zachary Goldhaber, Adrian F. Hernandez, Russell Douglas Hull, Alex Gold, Alexander Thomas Cohen, Robert A. Harrington et al. · 2017 · Journal of Thrombosis and Thrombolysis
20. Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
    Xue Zhou, Zuolan Wang, Shuang Dou, Kang‐Yin Chen, Enzhao Liu, Tong Liu, Guangping Li, Jingjin Che · 2020 · Cardiology Research and Practice
21. Safety and efficacy of direct oral anticoagulants in comparison with warfarin across different BMI ranges: A systematic review and meta-analysis
    Talal Almas, Faeez Muhammad, Laiba Siddiqui, Batool Shafi, Rabbia Gul, Rafiya Altaf, Zaeem Ahmed Abbasi, Ghulam Mustafa, Arham Iqbal, Amatul Rehman Durdana et al. · 2022 · Annals of Medicine and Surgery
22. Cardiac Remodeling, Circulating Biomarkers and Clinical Events in Patients with a History of Atrial Fibrillation. Data from the GISSI-AF Trial
    on the behalf of the GISSI-AF Investigators, Lidia Irene Staszewsky, Serge Masson, Simona Barlera, Marcello Disertori, Silvana Boni, Daniele Bertoli, Olga Vriz, Elena Pasotti, Prisca Zeni et al. · 2015 · Cardiovascular Drugs and Therapy
23. Development and external validation of predictive models for prevalent and recurrent atrial fibrillation: a protocol for the analysis of the CATCH ME combined dataset
    Winnie Chua, Christina Easter, Eduard Guasch, Alice J. Sitch, Barbara Casadei, Harry J.G.M. Crijns, Doreen Haase, Stéphane N. Hatem, Stefan Kääb, Lluı́s Mont et al. · 2019 · BMC Cardiovascular Disorders
24. Evaluation of the Age, Biomarkers, and Clinical History–Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials
    Ziad Hijazi, Jonas Oldgren, Johan Lindbäck, John Hunter Alexander, Marco Alings, Raffaele De Caterina, John W. Eikelboom, Michael D. Ezekowitz, Claes Held, Kurt Huber et al. · 2020 · JAMA Network Open
25. Duration of atrial fibrillation and cardiac biomarkers are associated with cardiovascular outcomes in early permanent atrial fibrillation: Data from the RACE II study
    Marieke J H Velt, Isabelle C. Van Gelder, Harry J.G.M. Crijns, Michiel Rienstra, Bart A. Mulder · 2025 · International Journal of Cardiology
26. Misconceptions and Facts About Atrial Fibrillation
    Edgar Argulian, David Conen, Franz H. Messerli · 2015 · The American Journal of Medicine
27. Coagulation Biomarkers and Clinical Outcomes in Elderly Patients With Nonvalvular Atrial Fibrillation
    Yukihiro Koretsune, Takeshi Yamashita, Masaharu Akao, Hirotsugu Atarashi, Takanori Ikeda, Ken Okumura, Wataru Shimizu, Shinya S. Suzuki, Hiroyuki Tsutsui, Ḱazunori Toyoda et al. · 2023 · JACC Asia
28. Prognostic Value of Serum N-Terminal Pro-Brain Natriuretic Peptide Level over Heart Failure for Stroke Events and Deaths in Patients with Atrial Fibrillation
    Keiichiro Kuronuma, Yasuo Okumura, Tomoyuki Morikawa, Katsuaki Yokoyama, Naoya Matsumoto, Eizo Tachibana, Koji Oiwa, Michiaki Matsumoto, Toshiaki Kojima, Hironori Haruta et al. · 2020 · International Heart Journal
29. Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHA2DS2-VASc–Biomarkers model
    Samuel Short, Katherine S. Wilkinson, Erin Mathiesen Hald, George Howard, Virginia J. Howard, Suzanne E. Judd, Elsayed Z. Soliman, Brett M. Kissela M. D, David Robinson, Robert J. Stanton et al. · 2025 · Journal of Thrombosis and Haemostasis
30. Venous thromboembolism and bleeding in cancer patients: role of inflammatory and cardiac biomarkers
    Danielle Carole Roy, Tzu‐Fei Wang, Ranjeeta Mallick, Dylan E Burger, Marc Carrier, Philip Stephen Wells, Steven Hawken · 2025 · European Heart Journal
31. Predictive Role of BNP/NT-proBNP in Non-Heart Failure Patients Undergoing Catheter Ablation for Atrial Fibrillation: An Updated Systematic Review
    Νικόλαος Παπαγεωργίου, Rui Andre Providencia, Debbie Falconer, Tanakal Wongwarawipat, Dimitris Tousoulis, Wei Yao Lim, ANTHONY W.C. CHOW, RICHARD JOHN SCHILLING, Pier David Lambiase · 2019 · Current Medicinal Chemistry
32. Left Atrial Appendage Thrombus in Patients with Nonvalvular Atrial Fibrillation before Catheter Ablation and Cardioversion: Risk Factors beyond the CHA2DS2-VASc Score
    Yangwei Cai, Qingsong Xiong, Shaojie Chen, Xi Jiang, Jia Liao, Weijie Chen, Lili Zou, Lei Su, Yefeng Zhu, Yuehui Yin et al. · 2022 · Journal of Cardiovascular Development and Disease
33. N‐terminal pro‐B‐type natriuretic peptide and D‐dimer combined with left atrial diameter to predict the risk of ischemic stroke in nonvalvular atrial fibrillation
    Zican Shen, Dong Chen, Hao Cheng, Feng Tan, Jianwei Yan, Haiming Deng, Wei Fang, Sunan Wang, Jianbing Zhu · 2022 · Clinical Cardiology
34. N‐terminal pro‐B‐type natriuretic peptide improves the predictive value of CHA2DS2‐VASc risk score for long‐term cardiovascular events in acute coronary syndrome patients with atrial fibrillation
    Xuefei Mu, Miaohan Qiu, Yi Li, Ziqi Li, Bin Qi, Zilan Jing, Quanmin Jing · 2023 · Clinical Cardiology
35. Apixaban and oral implications
    Mónica Paula López-Galindo, José Vicente Bagán Sebastián · 2015 · Journal of Clinical and Experimental Dentistry
36. Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care
    Faris Ghazal, Holger Theobald, Mårten Rosenqvist, Faris Al-Khalili · 2019 · PLoS ONE
37. Association of natriuretic peptide and adverse outcomes in patients with atrial fibrillation: A meta‐analysis
    Hong Du, Lei Yang, Hui Zhang, Xiaolin Zhang, Huiyu Shao · 2020 · Clinical and Experimental Pharmacology and Physiology
38. Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation
    Julia Aulin, Karl Sjölin, Johan Lindbäck, Alexander Philipp Benz, John W. Eikelboom, Kim Kultima, Jonas Oldgren, Lars C. Wallentin, Joachim Burman · 2024 · Journal of the American Heart Association
39. Markers of Left Atrial Myopathy: Prognostic Usefulness for Ischemic Stroke and Dementia in People in Sinus Rhythm
    Gabriele Masini, Wendy Wang, Yuekai Ji, Anne A. Eaton, Riccardo Maria Inciardi, Elsayed Z. Soliman, ROD S. PASSMAN, Scott David Solomon, Amil M. Shah, Raffaele De Caterina et al. · 2025 · Stroke
40. Role of New Potential Biomarkers in the Risk of Thromboembolism in Atrial Fibrillation
    Mario Piergiulio Pezzo, Antonella Tufano, Massimo Franchini · 2022 · Journal of Clinical Medicine
41. Fine Tuning Risk Stratification for Atrial Fibrillation
    Richard William Troughton, Ian Crozier · 2013 · Journal of the American College of Cardiology
42. N-terminal pro-brain natriuretic peptide levels had an independent and added ability in the evaluation of all-cause mortality in older Chinese patients with atrial fibrillation
    Shihui Fu, Jie Jiao, Yi Guo, Bing Zhu, Leiming Luo · 2019 · BMC Geriatrics
43. The ABC-Stroke Score Refines Stroke Risk Stratification in Patients With Atrial Fibrillation at the Emergency Department
    Jan Daniel Niederdöckl, Julia Oppenauer, Sebastian Schnaubelt, Filippo Cacioppo, Nina Buchtele, Alexandra-Maria Warenits, Roberta Laggner, Nikola Schütz, Magdalena Sophie Boegl, Gerhard Ruzicka et al. · 2022 · Frontiers in Medicine
44. Longitudinal analysis of echocardiographic and cardiac biomarker variables in dogs with atrial fibrillation: The optimal rate control in dogs with atrial fibrillation II study
    Brigite Pedro, Antonia Mavropoulou, Mark A. Oyama, Chris Linney, J. Neves, Joanna Dukes‐McEwan, Ana Patrícia Fontes-Sousa, Anna R. Gelzer · 2024 · Journal of Veterinary Internal Medicine
45. The soluble ST2 level predicts risk of atrial fibrillation recurrences in long-term period after radiofrequency ablation
    Tatiana P. Gizatulina, Aleksandra V. Mamarina, L. U. Martyanova, Д. В. Белоногов, Г. В. Колунин, Tatiana Ivanovna Petelina, Широков Никита Евгеньевич, Е. А. Горбатенко · 2024 · BMC Cardiovascular Disorders
46. Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation
    Katrine Enge, Arnljot Tveit, Steve Enger, Sophia Onarheim, Are Hugo Pripp, Peter Selmer Rønningen, Magnar Gangås Solberg, Rune Byrkjeland, Kristoffer Andresen, Anders Halsen et al. · 2024 · European Heart Journal - Cardiovascular Pharmacotherapy
47. Soluble urokinase plasminogen activator receptor ( suPAR ) as a prognostic biomarker in acutely admitted patients with atrial fibrillation
    Frederik Dencker Wisborg, Nora Olsen El Caidi, Ida Arentz Taraldsen, Sandra Henriette Tonning, Aginsha Kandiah, Mohammed El‐Sheikh, Hashmat Sayed Zohori Bahrami, Ove Andersen, Line Jee Hartmann Rasmussen, Jens Dahlgaard Hove et al. · 2025 · Journal of Arrhythmia
48. Impact of BNP level and peak VO2 on future heart failure events: comparison between sinus rhythm and atrial fibrillation
    Yuko Kato, Shinya S. Suzuki, Tokuhisa Uejima, Hiroaki Semba, Hiroto Kano, Shunsuke Matsuno, Hideaki Takai, Takayuki Otsuka, Yuji Oikawa, Kazuyuki Nagashima et al. · 2016 · Heart and Vessels
49. BNP combined with echocardiographic parameters to predict the risk of cardioembolic stroke
    Meng Zhang, Yuan Wang, Jin Wei, Qing Peng, Xudong Pan, Aijun Ma · 2021 · Journal of Clinical Neuroscience
50. Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus
    Kyuhyun Lee, Soo Kyoung Lee, Juyeon Lee, Bo Kyung Jeon, Tae‐Hoon Kim, Hee Tae Yu, Jung‐Myung Lee, Jin‐Kyu Park, Yong‐Soo Baek, Dong‐Hyeok Kim et al. · 2023 · PLoS ONE
51. The role of NT-proBNP in screening for atrial fibrillation in hypertensive disease
    Gina Sado, Katrin Kemp Gudmundsdottir, Carl Bonander, Mattias Ekström, Johan Engdahl, Emma Svennberg · 2024 · IJC Heart & Vasculature
52. New Oral Anticoagulants in Heart Failure
    Isabelle C. Van Gelder, Dirk Jan van Veldhuisen, Gregory Y.H. Lip · 2013 · European Journal of Heart Failure
53. Viewpoint: Stroke Prevention in Recent Guidelines for the Management of Patients with Atrial Fibrillation: An Appraisal
    Tatjana Potpara, Gregory Y.H. Lip, Carina Blomström‐Lundqvist, Chern‐En Chiang, A. John Camm · 2017 · The American Journal of Medicine
54. Betrixaban for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients: Putting the APEX Results into Practice
    Kayla M. Miller, Michael J. Brenner · 2019 · Drugs
55. Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial
    Helge Rørvik Røsjø, Ziad Hijazi, Torbjørn Omland, Johan Westerbergh, Magnus Nakrem Lyngbakken, John Hunter Alexander, Bernard John Gersh, Christopher Bull Granger, Elaine M. Hylek, Renato D. Lópes et al. · 2020 · Journal of Internal Medicine
56. Biomarkers and atrial fibrillation: is it prime time yet?
    Rajiv Mahajan, Dennis H. Lau, Prashanthan Sanders · 2014 · Heart
57. Higher N-Terminal Pro–B-Type Natriuretic Peptide May Be Related to Very Different Conditions
    Şevket Balta, Saıt Demırkol, Mehmet Aydogan, Turgay Celık · 2013 · Journal of the American College of Cardiology
58. Natriuretic peptide should be used as a routine tool for evaluation of patients with atrial fibrillation
    Ziad Hijazi, Lars C. Wallentin · 2018 · Heart
59. Association between obesity and short- and medium-term mortality in critically ill patients with atrial fibrillation: a retrospective cohort study
    Duo Yang, Shujun Ye, Kaihong Zhang, Zhiliang Huang, Longsheng Zhang · 2023 · BMC Cardiovascular Disorders
60. Association Between Atrial Fibrillation Symptoms and Clinical Outcomes: A Prospective Multicenter Registry Study
    Sang Jun Lee, Junbeom Park, Jin‐Kyu Park, Ki‐Woon Kang, Jae‐Sun Uhm, Eue‐Keun Choi, Jun Kim, Jin‐Bae Kim, Young Soo Lee, Hyung Wook Park et al. · 2024 · The American Journal of Cardiology
61. The predictive role of N-terminal pro-B-type natriuretic peptide in assessing outcomes for atrial fibrillation patients, with or without heart failure: a comprehensive systematic review and meta-analysis
    Afina Syarah Lidvihurin, Yusuf Ananda Fikri · 2024 · Cardiology Plus
62. Global Research Progress on Radiofrequency Ablation in Cardiology
    Chukwuka Elendu, Nkechi P. Ogwu, Alexander U. Okatta, Eunice Omeludike, Emmanuel C. Ogelle, Babajide T. Obidigbo, Mary C. Joseph, Emmanuella I. Osamuyi, Afeez O. Ogidan, Klein A. Jingwa et al. · 2024 · Annals of Medicine and Surgery
63. The Differential Diagnostic Value of Serum NT‐proBNP in Hospitalized Patients of Heart Failure With Pneumonia
    Shuangshuang Yang, Linbin Li, Ju Cao, Hongsong Yu, Huajian Xu · 2014 · Journal of Clinical Laboratory Analysis
64. Validation of Biomarker-Based ABCD Score in Atrial Fibrillation Patients with a Non-Gender CHA2DS2-VASc Score 0–1: A Korean Multi-Center Cohort
    Moonki Jung, Kyeongmin Byeon, Ki‐Woon Kang, Yae Min Park, You Mi Hwang, Sung Ho Lee, Eun‐Sun Jin, Seung‐Young Roh, Jin Seok Kim, Jinhee Ahn et al. · 2022 · Yonsei Medical Journal
65. Risk prediction of atrial fibrillation and its complications in the community using hs troponin I
    Christin S. Börschel, Bastiaan Geelhoed, Teemu Niiranen, Stephan Camen, Maria Benedetta Donati, Aki Samuli Havulinna, Francesco Gianfagna, Tarja Palosaari, Pekka Jousilahti, Jukka P. Kontto et al. · 2023 · European Journal of Clinical Investigation
66. Value of N-Terminal Pro-Brain Natriuretic Peptide for Embolic Events Risk Prediction in Patients with Atrial Fibrillation; a Systematic Review and Meta-Analysis.
    Koohyar Ahmadzadeh, Amirali Hajebi, Hamzah Adel Ramawad, Yaser Azizi, Mahmoud Yousefifard · 2023 · Archives of Academic Emergency Medicine
67. Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation ( CS‐SPAF )
    Moonki Jung, Kyeongmin Byeon, Ki‐Woon Kang, Wang Soo Lee, Sang‐Wook Kim, Yae Min Park, You Mi Hwang, Sung Ho Lee, Eun‐Sun Jin, Seung‐Young Roh et al. · 2023 · Journal of Arrhythmia
68. The Importance of Nitric Oxide and Oxidative Stress in Atrial High-Rate Episodes in Patients with Cardiac Devices
    İnanç Artaç · 2024 · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
69. Comprehensive analysis of recurrence factors in cryoballoon AF ablation: integrating clinical, biomarkers, and echocardiographic parameters
    Ali Uğur Soysal, Asli Gulfidan, Damla Raimoglou, Adem Atıcı, Hakan Yalman, Mine Kücür, Sukriye Ebru Onder, Eser Durmaz, Barış İkitimur, Kıvanç Yalın · 2024 · The International Journal of Cardiovascular Imaging
70. A novel scoring system for stroke risk stratification in Japanese patients with low CHADS2 scores: Study using a transesophageal‐echocardiogram endpoint
    Daigo Nagahara, Naoyuki Kamiyama, Takefumi Fujito, Atsushi Mochizuki, Shinya Shimoshige, Tetsuji Miura · 2020 · Journal of Arrhythmia
71. Prognosis of elderly non-valvular atrial fibrillation patients stratified by B-type natriuretic peptide: ELDERCARE-AF subanalysis
    Osamu Okazaki, Yorihiko Higashino, Koichi Yokoya, Yoshimori An, Kimihiko Tanizawa, Yuki Imamura, Takuya Hayashi, Masaharu Akao, Ken Okumura, Takeshi Yamashita · 2022 · American Heart Journal
72. Predictive Value of N-Terminal Pro B-Type Natriuretic Peptide for Short-Term Outcome of Cardioversion in Patients with First-Diagnosed or Paroxysmal Atrial Fibrillation Presenting to the Emergency Department
    A Diakantonis, Christos Verras, Sofia Bezati, Vasiliki Bistola, Ioannis Ventoulis, Maria Velliou, Antonios Boultadakis, Ignatios Ikonomidis, John Parissis, Effie Polyzogopoulou · 2024 · Biomedicines
73. Direct Oral Anticoagulants in Atrial Fibrillation
    Georg Noll, Sarah Noll, David Hürlimann · 2014 · Seminars in Hematology
74. Use of Novel Oral Anticoagulants in Patients With Heart Failure
    Eduard Shantsila, Gregory Y.H. Lip · 2014 · Current Treatment Options in Cardiovascular Medicine
75. A targeted approach toward more accurate assessment of hypertension
    Dina Johar, Larry H. Bernstein · 2017 · Egyptian Journal of Chest Diseases and Tuberculosis
76. The ABC-Death Score for Mortality Prediction in Patients With Atrial Fibrillation Undergoing Catheter Ablation
    Yufeng Wang, Chao Jiang, Liu He, Xin Du, Xueyuan Guo, Ribo Tang, Caihua Sang, Deyong Long, Jianzeng Dong, Gregory Y.H. Lip et al. · 2023 · JACC Asia
77. Routinely available inflammation biomarkers to predict stroke and mortality in atrial fibrillation
    Long Wu, Zhiquan Yuan, Yuhong Zeng, Lanqing Yang, Qin Hu, Huan Zhang, Chengying Li, Yanxiu Chen, Zhihui Zhang, Li Zhong et al. · 2025 · Clinics
78. Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non–Vitamin K Oral Anticoagulants Across Varying Body Mass Index
    Astrid Fritz Hansson, Karin Jensevik, Christina Christersson, Claes Held, Gorav Batra · 2023 · Journal of the American Heart Association
79. Cardiac Biomarkers
    Allan S. Jaffe, Alan S. Maisel · 2016 · Springer eBooks
80. Emerging risk factors for stroke and bleeding in patients with atrial fibrillation and heart failure–a narrative review
    Zabierowski Jan, Bartosz Hudzik, Nowak Jolanta, Mariusz Gąsior · 2025 · Current Problems in Cardiology
81. Circulating biomarkers and ischemic stroke risk in adults with atrial fibrillation taking anticoagulation: the Reasons for Geographic And Racial Differences in Stroke study
    Samuel Short, Erin Mathiesen Hald, Katherine S. Wilkinson, George Howard, Virginia J. Howard, Suzanne E. Judd, Elsayed Z. Soliman, Brett M. Kissela M. D, David Robinson, Robert J. Stanton et al. · 2025 · Journal of Thrombosis and Haemostasis
82. Comment: Natriuretic peptides as predictive biomarkers of stroke outcome
    Bruce M. Coull · 2013 · Neurology
83. Highlights of the Year in JACC 2013
    Anthony Nicholas DeMaria, ERIC D. ADLER, Jeroen Joost Bax, Ori Ben‐Yehuda, Gregory K. Feld, Barry Greenberg, Jennifer L. Hall, Mark Andrew Hlatky, Wilbur Y.W. Lew, João A.C. Lima et al. · 2014 · Journal of the American College of Cardiology
84. Thromboemboliás kockázat pitvarfibrillációban
    Zoltán Csanádi · 2016 · Orvosi Hetilap
85. Biomarkers in Arrhythmias, Sudden Death, and Device Therapy
    David E. Krummen, Lori B. Daniels · 2016 · Springer eBooks
86. Antithrombotic Therapy for Patients with Atrial Fibrillation
    Kyla M. Lara, Jonathan L. Halperin · 2018 · Springer eBooks
87. New Role of Biomarkers in Atrial Fibrillation
    Ana I. Rodríguez-Serrano, María Asunción Esteve‐Pastor, Diana Hernández‐Romero, Mariano Valdés, Vanessa Roldán, Francisco R. Marín · 2016 · Springer eBooks
88. Amplitude das Ondas F como Preditor de Tromboembolismo e de Sucesso da Cardioversão Elétrica em Pacientes com Fibrilação Atrial Persistente
    Renan Teixeira Campelo, Luciana Armaganijan, Dalmo Antônio Ribeiro Moreira, Matheus Kiszka Scheffer, Guilherme Dagostin de Carvalho, João Ítalo Dias França · 2022 · Arquivos Brasileiros de Cardiologia
89. [Biomarkers and atrial fibrillation : Prediction of recurrences and thromboembolic events after rhythm control management].
    Jelena Kornej, Katja Schumacher, Daniela Husser, Gerhard Hindricks · 2018 · PubMed
90. Controversies in Antithrombotic Therapy for Patients With Coronary Artery Disease and Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Literature Review
    Omar Almur, Baraa Emran, Fathi S Milhem, Qutayba Z. Ayaseh, Abdelfattah M. Dahmas, Maram M. Abukhalil, Sakeena Saife, Mohammad Bdair, Ayesha Younas, Haroun Neiroukh et al. · 2025 · Clinical Medicine Insights Cardiology
91. Vascular cell adhesion molecule 1: a marker for atrial fibrillation and heart failure risk
    Jonas Alexander Baadsgaard, Oliver Bundgaard Vad, August Krebs Hessellund, Søren Zöga Diederichsen, Christian Paludan‐Müller, Jesper Hastrup Svendsen · 2025 · EP Europace
92. Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure
    Tymon Pol, Johan Lindbäck, Jonas Oldgren, John Hunter Alexander, Agneta Siegbahn, Lars C. Wallentin, Ziad Hijazi · 2026 · Journal of the American Heart Association
93. Blood Biomarkers and the Risk of Coronary Disease in Atrial Fibrillation
    Andres M. Cordova Sanchez, Katherine S. Wilkinson, Samuel Short, Virginia J. Howard, Suzanne E. Judd, Parag Goyal, Elsayed Z. Soliman, Emily B. Levitan, Monika M. Safford, Mary Cushman · 2026 · Journal of the American Heart Association
94. NT-proBNP in relation to clinical characteristics and cardiovascular outcomes in non-anticoagulated patients with atrial fibrillation
    Maria Tomasdottir, Jonas Oldgren, Johan Lindbäck, Alexander Philipp Benz, John W. Eikelboom, Agneta Siegbahn, Lars C. Wallentin, Ziad Hijazi · 2026 · Heart
95. Who will benefit from anticoagulant therapy? Use of the CHADS2 score and its variants
    Greg Flaker, Atul Singla, Mayank Mittal · 2014 · Research Reports in Clinical Cardiology
96. New Role of Biomarkers in Atrial Fibrillation
    Ana I. Rodríguez-Serrano, María Asunción Esteve‐Pastor, Diana Hernández‐Romero, Mariano Valdés, Vanessa Roldán, Francisco R. Marín · 2015 · Springer eBooks
97. Contemporary approach to stroke prevention in atrial fibrillation: Risks, benefits, and new options
    Jonathan Stock, Brian J. Malm · 2018 · Trends in Cardiovascular Medicine
98. Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response
    Nicola Tidbury, Joshua Preston, Wern Yew Ding, José Miguel Rivera‐Caravaca, Francisco R. Marín, Gregory Y.H. Lip · 2020 · Expert Review of Precision Medicine and Drug Development
99. Risk Stratification For and Use of DOAC Therapies for Stroke Prevention in Patient with Atrial Fibrillation
    Alfredo Caturano, Raffaele Galiero, Serenella Spiezia, Pia Clara Pafundi · 2021 · Springer eBooks
100. News on angiotensin II and atrial fibrillation : from the molecular to the pathophysiological.
     Andrés Elías Llamas Nieves, Iván David Lozada-Martínez, Daniela M. Torres-Llinás, Fernando Manzur-Jattin, Miguel Ángel Cardales Periñán · 2021 · Revista Ciencias Biomédicas